Back to Search
Start Over
Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain.
- Source :
-
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Sep 20; Vol. 31, pp. 101105. Date of Electronic Publication: 2023 Sep 20 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Competing Interests: D.S. and M.A. have sponsored research agreements with Excision Biosciences. K.R.J. holds equity in Excision Biosciences and Caladan Therapeutics.
Details
- Language :
- English
- ISSN :
- 2329-0501
- Volume :
- 31
- Database :
- MEDLINE
- Journal :
- Molecular therapy. Methods & clinical development
- Publication Type :
- Periodical
- Accession number :
- 37753219
- Full Text :
- https://doi.org/10.1016/j.omtm.2023.09.001